June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Platinum rallies for third day on economic rebound hopes

Published 16/02/2021, 12:26 pm
© Reuters.
XAU/USD
-
XAG/USD
-
AZN
-
GC
-
SI
-
PA
-
PL
-
AZN
-
SSWJ
-
DXY
-

Feb 16 (Reuters) - Platinum prices rallied for a third straight session on Tuesday, hitting a near six-and-a-half-year peak on hopes that a swift global economic rebound would boost demand for the auto-catalyst metal.

FUNDAMENTALS

* Platinum XPT= rose 1% to $1,315.32 by 0102 GMT, after hitting its highest since September 2014 at $1,320.50.

* The metal is used by automakers for catalytic converter manufacturing to clean car exhaust fumes.

* Platinum may see a third consecutive annual deficit in 2021 amid supply concerns from South Africa, the world's largest platinum producer. South African miner Sibanye-Stillwater SSWJ.J on Monday reported a 40% increase in 4E Platinum Group Metals (PGM) mineral reserves at its SA PGM operations. Palladium XPD= , also used in the auto sector, climbed 0.3% to $2,394.57, having hit a one-month peak of $2,415.68 in the previous session.

* Spot gold XAU= edged up 0.1% to $1,820.71 per ounce. U.S. gold futures GCv1 slipped 0.1% to $1,822.10, while silver XAG= gained 0.2% to $27.63.

* The dollar .DXY eased against rivals, making gold more affordable. USD/

* Benchmark U.S. Treasury yields rose to their highest levels since March. US/

* Global shares held firm on Tuesday, looking to extend their bull run to a 12th consecutive session as optimism about the global economic recovery and expectations of low interest rates drive investments into riskier assets. MKTS/GLOB

* Market participants now await minutes of the Federal Reserve's end-January monetary policy meeting on Wednesday.

* The euro zone is likely to decide between March and May when and how governments would start tapering support to their economies as vaccinations allow the lifting of pandemic lockdowns and economic activity picks up, officials said on Monday. The World Health Organization on Monday listed AstraZeneca (NASDAQ:AZN) AZN.L and Oxford University's COVID-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.